542934 — Chandra Bhagat Pharma Balance Sheet
0.000.00%
- IN₹441.39m
- IN₹641.97m
- IN₹867.16m
Annual balance sheet for Chandra Bhagat Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 28.2 | 59 | 65.5 | 51 | 8.02 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 318 | 280 | 212 | 794 | 948 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 700 | 707 | 581 | 979 | 975 |
Net Property, Plant And Equipment | 4.23 | 4.73 | 7.28 | 25.2 | 26.2 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 718 | 725 | 606 | 1,018 | 1,015 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 329 | 381 | 269 | 711 | 692 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 459 | 458 | 331 | 728 | 716 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 259 | 267 | 275 | 290 | 300 |
Total Liabilities & Shareholders' Equity | 718 | 725 | 606 | 1,018 | 1,015 |
Total Common Shares Outstanding |